With expertise in enforcement, cartelisation, and leniency matters, as well as merger controls, M&A transactions, and restructuring, Khaitan & Co LLP‘s antitrust and competition practice is capable of handling a wide range of matters, both domestically and internationally. The group has particular strengths in the manufacturing, steel, and technology sectors, and its notable client roster continues to expand. Anshuman Sakle heads up the practice and is highly regarded in the market for his extensive experience advising on merger control matters, abuse of dominance and cartel investigations, and joint venture and distribution agreements, alongside regulatory compliance and antitrust audits. He is instructed by businesses from a wide range of industries including financial services, pharmaceutical, and infrastructure. Other notable names in the team are Manas Kumar Chaudhuri, who frequently acts before the CCI and the NCLAT and is adept at advising on cross-border merger control cases, as well as Anisha Chand and Pranjal Prateek.
Legal 500 redaktioneller Kommentar

Auszeichnungen

Mandantenzufriedenheit

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • ‘The team stands out for its exceptional expertise, strong client relationships, innovative problem solving, integrity and professionalism, and dedication to client success.’

  • ‘This is a great team who understands the client's concerns and provides relevant advice.’

Kernmandanten

  • Ipca Laboratories Limited and Unichem Laboratories Limited
  • Abu Dhabi Ports
  • India Resurgence Fund
  • Power Finance Corporation Limited
  • The Orogen Group
  • Dalmia Cement (Bharat) Limited
  • Nirma Limited
  • Magna International Inc.
  • Insight Luxembourg XII S.a.r.l.
  • Shree Cement Limited

Highlight-Mandate

  • Assisted Ipca Laboratories Ltd in securing approval for the 100% acquisition of Unichem.
  • Assisted Abu Dhabi Ports Company on securing unconditional approval for the acquisition of Delanord Investments Ltd.
  • Represented Nirma in seeking unconditional approval from the CCI for its acquisition of a majority shareholding of Glenmark Life Sciences Ltd.

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Manas Kumar Chaudhuri
Anshuman Sakle

Partner*innen der nächsten Generation

Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.

Anisha Chand
Pranjal Prateek

Praxisleitung

Anshuman Sakle

Weitere Kernanwält*innen

Manas Kumar Chaudhuri; Anisha Chand; Pranjal Prateek; Soham Banerjee